Pharmplus Limited
11460548
Healthy
- 4 outstanding charges (-8)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 11/07/2018
MANAGER
BRITISH · UNITED KINGDOM · Age 37
Also on 5 other boards
Persons with Significant Control
Pharmplus2 Ltd
83, Hall Green Street, Bilston, WV14 8TH
Reg: 12471802 · England & Wales · Private Company Limited By Shares
Notified 12/07/2025
Former PSCs
Mr Abbaas Tariq
Ceased 12/07/2025
Mr Arsalan Hafiz Khan
Ceased 12/07/2025
Charges4 outstanding
BARCLAYS SECURITY TRUSTEE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
BARCLAYS SECURITY TRUSTEE LIMITED
WESLEYAN BANK LIMITED
CompanyRankvs 2975+ SIC 86210 peers67
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/03/2025
Net Worth
£283k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£404k
Working capital
Current Assets
£867k
Current Liabilities
£463k
Fixed Assets
£928k
Tax at Year End(2022)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.87 | -£24k |
| 2024 | 2.14 | +£47k |
| 2023 | 2.42 | +£58k |
| 2022 | 1.35 | +£150k |
| 2021 | 1.00 | +£69k |
| 2020 | 0.55 | — |
Derived from filed accounts. Not audited figures.